SelectQuote

SLQT · NYSE

$0.3039−$0.0132 (−4.16%)TodayMarket closed ·
Prev close $0.3171

SLQT analyst rating

HoldConsensus of 1 analyst over the last 12 months. 0% rate it a buy.
  • Strong buy0
  • Buy0
  • Hold1
  • Underperform0
  • Sell0

12-month price target · 6 analysts

Average $2.36 (+676.2% upside)

Low
$1.26
Now
$0.3039
High
$3.15

Upgrades and downgrades

The latest rating actions, newest first

SLQT analyst upgrades, downgrades and rating actions
FirmDateActionRating
RBC CapitalFeb 11, 2026MaintainsSector Perform
RBC CapitalNov 20, 2025MaintainsSector Perform

The case for and against

Updated Jan 26, 2026

Bull case

SelectQuote Inc. demonstrates a positive outlook supported by the growth and increasing significance of its Healthcare Services segment, which is characterized by high revenue visibility and attractive economics, thus reducing overall business risk. The company's adjusted growth estimate for Medicare Advantage approved policies has been raised to 6.5% for fiscal 2026, reflecting a strong potential for increased consumer engagement and proactive workforce investments in anticipation of the Annual Enrollment Period (AEP). This strategic positioning enhances SelectQuote's ability to capture market share, reinforcing its revenue-generating capabilities across its key segments.

Bear case

SelectQuote Inc. is projected to experience a decline in approved Medicare Advantage (MA) policies by 3.9% year-over-year for FY25, largely attributed to a lower headcount within the company. The potential return of persistency headwinds could further exacerbate financial challenges, leading to negative tail-revenue and reduced cash flow from commissions. Additionally, these factors are expected to impose a significant 20% headwind on the company's adjusted EBITDA estimates, reinforcing a negative outlook on the stock.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.